Urokinase-Type Plasminogen Activator, antagonists & inhibitors

Name

Urokinase-Type Plasminogen Activator, antagonists & inhibitors

Accession Number

DBCAT001728

Description

Not Available

Drugs

Drug	Drug Description
Epigallocatechin gallate	Epigallocatechin gallate has been investigated for the treatment of Hypertension and Diabetic Nephropathy.
Upamostat	Upamostat has been used in trials studying the treatment of Pancreatic Cancer.
Urokinase	A low molecular weight form of human urokinase used to treat pulmonary embolism and myocardial infarction as well as to clear IV lines.

Drugs & Drug Targets

Drug	Target	Type
Epigallocatechin gallate	Aryl hydrocarbon receptor	target
Epigallocatechin gallate	DNA (cytosine-5)-methyltransferase 1	target
Epigallocatechin gallate	Dihydrofolate reductase, mitochondrial	target
Urokinase	Urokinase plasminogen activator surface receptor	target
Urokinase	Plasminogen	target
Urokinase	Plasminogen activator inhibitor 2	target
Urokinase	Plasminogen activator inhibitor 1	target
Urokinase	Plasma serine protease inhibitor	target
Urokinase	Nidogen-1	target
Urokinase	Low-density lipoprotein receptor-related protein 2	target
Urokinase	Suppressor of tumorigenicity 14 protein	target
Urokinase	Macrophage metalloelastase	enzyme